Reactive oxygen species (ROS)-responsive size-reducible nanoassemblies for deeper atherosclerotic plaque penetration and enhanced macrophage-targeted drug delivery
Open Access
- 7 April 2022
- journal article
- research article
- Published by KEAI Publishing in Bioactive Materials
- Vol. 19, 115-126
Abstract
Nanoparticle-based therapeutics represent potential strategies for treating atherosclerosis; however, the complex plaque microenvironment poses a barrier for nanoparticles to target the dysfunctional cells. Here, we report reactive oxygen species (ROS)-responsive and size-reducible nanoassemblies, formed by multivalent host-guest interactions between β-cyclodextrins (β-CD)-anchored discoidal recombinant high-density lipoprotein (NP3ST) and hyaluronic acid-ferrocene (HA-Fc) conjugates. The HA-Fc/NP3ST nanoassemblies have extended blood circulation time, specifically accumulate in atherosclerotic plaque mediated by the HA receptors CD44 highly expressed in injured endothelium, rapidly disassemble in response to excess ROS in the intimal and release smaller NP3ST, allowing for further plaque penetration, macrophage-targeted cholesterol efflux and drug delivery. In vivo pharmacodynamicses in atherosclerotic mice shows that HA-Fc/NP3ST reduces plaque size by 53%, plaque lipid deposition by 63%, plaque macrophage content by 62% and local inflammatory factor level by 64% compared to the saline group. Meanwhile, HA-Fc/NP3ST alleviates systemic inflammation characterized by reduced serum inflammatory factor levels. Collectively, HA-Fc/NP3ST nanoassemblies with ROS-responsive and size-reducible properties exhibit a deeper penetration in atherosclerotic plaque and enhanced macrophage targeting ability, thus exerting effective cholesterol efflux and drug delivery for atherosclerosis therapy.Keywords
Funding Information
- National Natural Science Foundation of China (81773669, 82073788)
- National Major Science and Technology Projects of China (2017YFA0205400)
This publication has 81 references indexed in Scilit:
- HDL endocytosis and resecretionBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2013
- Development of macromolecular prodrug for rheumatoid arthritisAdvanced Drug Delivery Reviews, 2012
- Macrophages in the Pathogenesis of AtherosclerosisCell, 2011
- Enzymatically-crosslinked injectable hydrogels based on biomimetic dextran–hyaluronic acid conjugates for cartilage tissue engineeringBiomaterials, 2010
- Controlled Storage of Ferrocene Derivatives as Redox-Active Molecules in DendrimersJournal of the American Chemical Society, 2010
- Oxidative stress in vascular disease: causes, defense mechanisms and potential therapiesNature Clinical Practice Cardiovascular Medicine, 2008
- Simvastatin has an anti-inflammatory effect on macrophages via upregulation of an atheroprotective transcription factor, Kruppel-like factor 2Cardiovascular Research, 2008
- The effect of statins on ABCA1 and ABCG1 expression in human macrophages is influenced by cellular cholesterol levels and extent of differentiationAtherosclerosis, 2008
- ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasisNature Reviews Molecular Cell Biology, 2007
- Triglycerides Are Major Determinants of Cholesterol Esterification/Transfer and HDL Remodeling in Human PlasmaArteriosclerosis, Thrombosis, and Vascular Biology, 1995